You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 10, 2024

ZOLPIMIST Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zolpimist, and when can generic versions of Zolpimist launch?

Zolpimist is a drug marketed by Aytu and is included in one NDA. There is one patent protecting this drug.

This drug has eighty-six patent family members in nine countries.

The generic ingredient in ZOLPIMIST is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zolpimist

A generic version of ZOLPIMIST was approved as zolpidem tartrate by ACME LABS on April 23rd, 2007.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ZOLPIMIST?
  • What are the global sales for ZOLPIMIST?
  • What is Average Wholesale Price for ZOLPIMIST?
Summary for ZOLPIMIST
International Patents:86
US Patents:1
Applicants:1
NDAs:1
Drug Prices: Drug price information for ZOLPIMIST
What excipients (inactive ingredients) are in ZOLPIMIST?ZOLPIMIST excipients list
DailyMed Link:ZOLPIMIST at DailyMed
Drug patent expirations by year for ZOLPIMIST
Drug Prices for ZOLPIMIST

See drug prices for ZOLPIMIST

US Patents and Regulatory Information for ZOLPIMIST

ZOLPIMIST is protected by one US patents.

Patents protecting ZOLPIMIST

Buccal, polar and non-polar spray containing zolpidem
Patent Number: ⤷  Sign Up
Patent Expiration: ⤷  Sign Up
Patented Use: TREATMENT OF TRANSIENT INSOMNIA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aytu ZOLPIMIST zolpidem tartrate SPRAY, METERED;ORAL 022196-001 Dec 19, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Premature patent expiration for: ZOLPIMIST

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
⤷  Sign Up ZOLPIMIST ⤷  Sign Up

International Patents for ZOLPIMIST

See the table below for patents covering ZOLPIMIST around the world.

Country Patent Number Title Estimated Expiration
Canada 2582018 PULVERISATEUR ORAL, POLAIRE ET NON POLAIRE, CONTENANT DU ZOLPIDEM (BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLPIDEM) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2004019909 ⤷  Sign Up
Australia 2003270014 BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING CARDIOVASCULAR OR RENAL DRUGS ⤷  Sign Up
European Patent Office 1539097 PULVERISATEUR OU CAPSULE BUCCALE POLAIRE ET NON POLAIRE CONTENANT DES MEDICAMENTS DESTINES A TRAITER DES ALLERGIES OU L'ASTHME (BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING ALLERGIES OR ASTHMA) ⤷  Sign Up
Japan 2010241843 BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING CARDIOVASCULAR OR RENAL DRUGS ⤷  Sign Up
Canada 2582265 PULVERISATEUR BUCCAL, POLAIRE ET NON POLAIRE CONTENANT DU PROPOFOL (BUCCAL, POLAR AND NON-POLAR SPRAYS CONTAINING PROPOFOL) ⤷  Sign Up
Japan 2001517689 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ZOLPIMIST

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2236132 92636 Luxembourg ⤷  Sign Up PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES
2236132 122015000006 Germany ⤷  Sign Up PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
2236132 CA 2015 00004 Denmark ⤷  Sign Up PRODUCT NAME: ZOLPIDEM OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ZOLPIDEMTARTRAT; NAT. REG. NO/DATE: 47607 OG 47608 20120719; FIRST REG. NO/DATE: (B BE424286 OG BE424295 20120718
2236132 300714 Netherlands ⤷  Sign Up PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 108438 - 439 20160624; REGISTRATION NO/DATE: BE424286 20120718 BE424295 20120718
2236132 C300714 Netherlands ⤷  Sign Up PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 108438 - 439 20130624; FIRST REGISTRATION: BE424286BE424295 2012180718
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.